NASDAQ
Antibe Therapeutics Inc. (ATBPF) has a eps (diluted) of $-0.37 as of Friday, March 31, 2023. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.